|
| |
| | | 62492 | | 04.10.2012 | | Boehringer Ingelheim (Schweiz) GmbH | | | | | | | | | | | | | 07.06.20. | | | | 07.06.20. | | IPro |
| | Seq.-nr. | Préparation | Description | Forme galénique | Classe d'ATC | |
|---|
| 01 | Jentadueto 2.5 mg/500 mg | Filmtabletten | Comprimés filmés (Linagliptinum 2.5 mg, Metformine Hydrochloride 500 mg) | A10BD11 | IPat | | 02 | Jentadueto 2.5 mg/850 mg | Filmtabletten | Comprimés filmés (Linagliptinum 2.5 mg, Metformine Hydrochloride 850 mg) | A10BD11 | IPat | | 03 | Jentadueto 2.5 mg/1000 mg | Filmtabletten | Comprimés filmés (Linagliptinum 2.5 mg, Metformine Hydrochloride 1000 mg) | A10BD11 | IPat |
|
|
|
